Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Meeting Our Goals (and Grantees) at a LRRK2 Meeting

    Meeting Our Goals (and Grantees) at a LRRK2 Meeting

    MJFF scientists presented and shared ideas at the Biochemical Society's Biennial International LRRK2 Meeting.
    Learn more
  • Next in Line for Parkinson's Therapies: PRKN and PINK1

    Next in Line for Parkinson's Therapies: PRKN and PINK1

    These genetic risk factors are teaching us more about what goes wrong in Parkinson's, and researchers are already testing therapies against them.
    Learn more
  • Changes in the Eye May Be a Window to Parkinson's Disease

    Changes in the Eye May Be a Window to Parkinson's Disease

    A study found people with Parkinson's had thinner retinas and those changes related to dopamine loss and physical symptoms.
    Learn more
  • Trials Testing New Therapies for Parkinson's Symptoms

    Trials Testing New Therapies for Parkinson's Symptoms

    Five clinical trials are recruiting volunteers to test new treatments for non-motor symptoms associated with Parkinson's disease.
    Learn more
  • Tests for Parkinson's within Reach

    Tests for Parkinson's within Reach

    Parkinson's scientists say tests to predict the course of the disease are within reach thanks to investment in large-scale studies and standardized methods.
    Learn more
  • What We Fund: Brain's Resilience, Asthma Drug for Parkinson's and Signs of Disease in the Eye

    What We Fund: Brain's Resilience, Asthma Drug for Parkinson's and Signs of Disease in the Eye

    Foundation-funded research lays groundwork to deepen understanding of Parkinson's and speed breakthroughs.
    Learn more
  • 'Scientific American' Talks LRRK2 and Parkinson's Research with MJFF CEO Todd Sherer

    'Scientific American' Talks LRRK2 and Parkinson's Research with MJFF CEO Todd Sherer

    An MJFF-funded study suggests that a drug targeting the LRRK2 genetic mutation may positively impact the broader PD population.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.